DNAe’s patented Genalysis™ platform is capable of delivering real-time, disposable, accurate on-the-spot tests for any target nucleic acid sequence (DNA/RNA).

The company’s IP portfolio includes:

• Label-free pH-mediated detection of DNA and RNA using semiconductor chips
• DNA sequencing using chip-based detection of hydrogen ions released from nucleotide incorporation
• novel low power electronic interfacing techniques
• methods for on-chip nucleic acid amplification
• methods for on-chip detection of Single Nucleotide Polymorphisms (SNPs)

Disposable lab-on-chip cartridges housing biochemical reagents, advanced microfluidics and low-power silicon biosensors are key to DNAe’s proprietary platform for the detection of genetic sequences or mutations. The micro-volume gene test reaction taking place on the fully-integrated cartridge is analysed in real-time by a portable handheld device using custom algorithms to ensure a robust and reliable result every time.

Built on the reliability, scalability and processing power of silicon chip technology, the Genalysis™ system is mass-producible and highly portable.

Genalysis™ cartridges can be tailored to any sequence of interest, human or microbial, making this a customisable platform technology amenable to a wide variety of applications and markets.